-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U3QELwSenovC/BjSIpAfZcIGT6+PT4E3Ejw+wu7b0yAoZXX4vJmU/O6pA592B/Yp 0yKUG3IPSezBZOkYC5ENtw== 0001169232-05-004345.txt : 20050825 0001169232-05-004345.hdr.sgml : 20050825 20050825111704 ACCESSION NUMBER: 0001169232-05-004345 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050819 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050825 DATE AS OF CHANGE: 20050825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 051047681 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 8-K 1 d65156_8-k.htm CURRENT REPORT

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

August 19, 2005

(Date of report)

 

CARACO PHARMACEUTICAL LABORATORIES, LTD.

(Exact name of registrant as specified in its charter)

 

 

Michigan

 

0-24676

 

38-2505723

(State or other jurisdiction of incorporation)

 

(Commission file number)

 

(I.R.S. employer identification no.)

 

 

1150 Elijah McCoy Drive, Detroit, Michigan 48202

(Address of principal executive offices)

 

(313) 871-8400

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 140.14a-12)

 

o 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On August 19, 2005, the Compensation Committee of the Board of Directors of registrant approved annual salaries (for fiscal year 2006, effective April 1, 2005) and eligibility for performance bonuses based on achievement of various criteria during fiscal year 2006 to its executive officers (other than the Chief Executive Officer) as follows:

 

Name

Title

Fiscal 2006

Salary

Fiscal 2006

Performance Bonus Eligibility

 

 

 

 

Jitendra N. Doshi

CFO & COO

$200,000

up to 30% of salary

 

 

 

 

Robert Kurkiewicz

Sr. V.P. - Technical

$152,250

up to 23% of salary

 

 

 

 

Gurpartap Singh

Sachdeva

V.P. – Sales &

Marketing

$175,500

up to 25% of salary

 

 

Item 9.01. Financial Statements and Exhibits

 

c)

Exhibits.

 

Exhibit No.

Description

 

10.16    Summary of fiscal year 2006 executive officer salaries and performance bonus eligibility (other than the Chief Executive Officer).

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CARACO PHARMACEUTICAL LABORATORIES, LTD.

 

 

 

Date:

August 25, 2005

By:     /s/ Daniel H. Movens
———————————————
Daniel H. Movens

Chief Executive Officer

 

 

 

 


 

 

Exhibit Index

 

10.16 Summary of fiscal year 2006 executive officer salaries and performance bonus eligibility (other than the Chief Executive Officer).

 

2

 


 EX-10.16 2 d65156_ex10-16.htm SUMMARY OF FISCAL 2006 EXEC OFFICER SALARIES

 

 

 

EXHIBIT 10.16

 

Summary of Fiscal Year 2006 Executive Officer Salaries and Performance Bonus Eligibility (Other than the Chief Executive Officer)       

 

           On August 19, 2005, the Compensation Committee of the Board of Directors of registrant approved annual salaries and eligibility for performance bonuses based on achievement of various criteria to the executive officers of registrant listed below as follows:

 

  Jitendra N. Doshi, the CFO and COO, receive an annual salary of $200,000 (for fiscal year 2006 and effective as of April 1, 2005), and be eligible for a performance bonus of up to 30% of salary based on achievement of various criteria during fiscal year 2006.

  Robert Kurkiewicz, the Senior Vice President-Technical receive an annual salary of $152,500 (for fiscal year 2006 and effective as of April 1, 2005), and be eligible for a performance bonus of up to 23% of salary based on achievement of various criteria during fiscal year 2006.

  Gurpartap Singh Sachdeva, the Vice President – Sales & Marketing, receive an annual salary of $175,500 (for fiscal year 2006 and effective as of April 1, 2005), and be eligible for a performance bonus of up to 25% of salary based on achievement of various criteria during fiscal year 2006.

 

 

3

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----